Where is it manufactured?
Actinomyces (121, 122), Prevotella (123), Bacteroides (120, 124), EscherichiaShigella (125) are the main species increased, whereas Mycobacterium , Lactobacillus , Enterobacter (123), Deltaproteobacteria , and Clostridiaceae decreased (126), including CB , FP , Clostridium leptum , Clostridium cluster XlVa , Clostridium cluster XlVb , Clostridium cluster XVIII (127)
Handling Protocols Use aseptic technique and clean equipment when preparing peptide solutions to prevent contamination
What the Evidence Says Current research supports GHK-Cus ability to drive tissue repair and reduce inflammation, though its use for systemic anti-aging in humans remains experimental, without large-scale clinical trials to date
Combination Potential Dual-action therapy: Survodutides unique approach may make it synergistic with other obesity drugs, though its primary use is expected as a standalone therapy
4,031.72 g/mol Purity 98% CAS No